Lupus & Connective Tissue Diseases
Commentary
Lupus classification criteria effort is going in the wrong direction
Advancing the development new classification criteria deserves a wider discussion among the field’s stakeholders.
Latest News
Self-injectable belimumab receives FDA approval for systemic lupus erythematosus
The new formulation is the first self-injectable subcutaneous treatment available for patients with SLE.
Conference Coverage
New classification system for systemic lupus erythematosus moves forward
Take our poll!
From the Journals
Drug combo improves RV contractility in scleroderma-PAH
New drug combo reduces sizes of the right heart chambers in patients with scleroderma-associated pulmonary arterial hypertension.
Conference Coverage
ANCA-associated vasculitis appears to increase risk of stroke, death
MADRID – But there was no higher risk for myocardial infarction.
Conference Coverage
Adverse childhood experiences link to worse SLE
MADRID – SLE patients might benefit from referrals to psychologists or social workers.
Conference Coverage
Algorithm for identifying IPF has low PPV
A revised version of a widely used code-based IPF algorithm could increase the rate of accurate diagnoses.
Conference Coverage
Prior mycobacterial infection linked to Sjögren’s syndrome
MADRID – Risk highest among those aged 40-65 years.
Feature
TWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitis
A member of the TNF superfamily of cytokines could be an attractive target for drugs to treat inflammation and autoimmune disease.
Conference Coverage
VIDEO: Cancer immunotherapies activate rheumatologic adverse effects
MADRID – “More than a quarter” of U.S. rheumatologists have seen a patient with immune checkpoint inhibitor–activated rheumatologic disease.
Conference Coverage
VIDEO: Troponin acts as atherosclerotic biomarker in patients with lupus
MADRID – Tropinin T levels may help assess cardiovascular risk in patients with lupus.